Community Corner

Salk Stem-Cell Research Shows Promise in Sickle-Cell Disease

Sickle-cell disease affecting 90,000 Americans.

Researchers at the Salk Institute for Biological Studies are using cells from sickle-cell patients to potentially cure the anemia-inducing condition that affects one in every 12 black Americans, it was announced Wednesday.

The method developed by Salk researchers also may be used to reverse other disorders linked to the same gene mutation implicated in sickle-cell disease.

Skin cells are used to generate what researchers call pluripotent stem cells, which can be manipulated to grow into almost any biological structure.

Find out what's happening in La Jollawith free, real-time updates from Patch.

“Our findings set the stage for the development of (stem-cell based therapies) for devastating genetic disorders such as sickle-cell disease,” said Juan Carlos Izpisua Belmonte, the lead author of the study and the head of Salk's Gene Expression Laboratory.

The defective gene behind the disease and others, which reduce the blood's ability to carry oxygen, is known as HBB, but traditional stem cell generation and gene therapy has proven potentially unsafe, because unwanted genes may be introduced, according to Belmonte.

Find out what's happening in La Jollawith free, real-time updates from Patch.

“We wanted to fix the mutation in such a way that it does not leave any unwanted traces in a patient's genome,” researcher Keiichiro Suzuki said.

Sickle-cell disease, affecting about 90,000 Americans, causes red blood cells to be malformed – sickle-shaped rather than round – and that leads to often painful circulatory problems. It is hereditary, affects mostly people of African descent and is caused by a defect in a gene underlying the production of hemoglobin, or oxygenated blood.

Sickle-cell disease is treatable and curable via stem cell or bone marrow transplants, but there is a high risk of the recipient rejecting donated cells or marrow, Belmonte said.

But because the stem cells are developed from the patient, the risk of rejection is vastly reduced.

The method will soon be tested on animals.

–City News Service


Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.

We’ve removed the ability to reply as we work to make improvements. Learn more here